Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: INDSWFTLAB and BSE: 532305 (ISIN INE915B01019).
It has a market capitalisation of ₹3,056 crore, a last close of ₹351.90 on 2026-10-19, a one-year return of 247.2%.
Valuation: a price-to-earnings ratio of 53.31x, a price-to-book ratio of 2.21x, a dividend yield of 0.0%.
Profitability: return on equity of 0.0%, return on capital employed of 3.8%, an operating margin of 9.0%.
Growth: sales growth of -19.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x, promoter holding of 42.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 3,056 |
| Last close | ₹351.90 |
| P/E (TTM) | 53.31x |
| P/B | 2.21x |
| Dividend yield | 0.0% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 3.8% |
| Operating margin (TTM) | 9.0% |
| Sales growth, 3-year CAGR | -19.0% |
| Debt / equity | 0.01x |
| Promoter holding | 42.9% |
| 1-year return | 247.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means